Woodline Partners’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Sell |
501,023
-290,000
| -37% | -$6.44M | 0.06% | 408 |
|
|
2025
Q1 | $14.7M | Buy |
791,023
+305,950
| +63% | +$5.69M | 0.1% | 285 |
|
|
2024
Q4 | $6.42M | Buy |
485,073
+25,094
| +5% | +$332K | 0.04% | 433 |
|
|
2024
Q3 | $15.4M | Buy |
459,979
+207,613
| +82% | +$6.96M | 0.13% | 222 |
|
|
2024
Q2 | $6.32M | Sell |
252,366
-256,473
| -50% | -$6.43M | 0.06% | 310 |
|
|
2024
Q1 | $11.5M | Sell |
508,839
-686,135
| -57% | -$15.5M | 0.11% | 239 |
|
|
2023
Q4 | $25.6M | Buy |
1,194,974
+354,153
| +42% | +$7.59M | 0.28% | 112 |
|
|
2023
Q3 | $15.1M | Sell |
840,821
-193,728
| -19% | -$3.48M | 0.18% | 164 |
|
|
2023
Q2 | $21M | Buy |
1,034,549
+574,987
| +125% | +$11.7M | 0.25% | 114 |
|
|
2023
Q1 | $10M | Sell |
459,562
-187,983
| -29% | -$4.09M | 0.14% | 198 |
|
|
2022
Q4 | $20.1M | Sell |
647,545
-462,617
| -42% | -$14.3M | 0.27% | 104 |
|
|
2022
Q3 | $28.3M | Buy |
1,110,162
+189,524
| +21% | +$4.83M | 0.4% | 67 |
|
|
2022
Q2 | $18.7M | Buy |
920,638
+86,711
| +10% | +$1.76M | 0.29% | 108 |
|
|
2022
Q1 | $20.6M | Buy |
833,927
+223,946
| +37% | +$5.54M | 0.33% | 87 |
|
|
2021
Q4 | $21.2M | Sell |
609,981
-403,975
| -40% | -$14M | 0.3% | 87 |
|
|
2021
Q3 | $27.5M | Buy |
1,013,956
+473,904
| +88% | +$12.9M | 0.45% | 55 |
|
|
2021
Q2 | $14M | Buy |
540,052
+111,205
| +26% | +$2.88M | 0.26% | 102 |
|
|
2021
Q1 | $9.24M | Buy |
+428,847
| New | +$9.24M | 0.21% | 124 |
|